Hemoperfusion Market, Global Outlook and Forecast 2023-2029

Hemoperfusion is a treatment technique in which large volumes of the patient's blood are passed over an adsorbent substance in order to remove toxic substances from the blood. Adsorption is a process in which molecules or particles of one substance are attracted to the surface of a solid material and held there. These solid materials are called sorbents.
This report aims to provide a comprehensive presentation of the global market for Hemoperfusion, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hemoperfusion. This report contains market size and forecasts of Hemoperfusion in global, including the following market information:
Global Hemoperfusion Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Hemoperfusion Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Hemoperfusion companies in 2022 (%)
The global Hemoperfusion market was valued at US$ 515.5 million in 2022 and is projected to reach US$ 1577.2 million by 2029, at a CAGR of 17.3% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
China is the largest Hemoperfusion market with about 65% market share. Europe is follower, accounting for about 19% market share.The key manufacturers are Jafron Biomedical, Baxter (Gambro), Asahi-Kasei, Biosun Medical, Kaneka, Toray Medical, Cytosorbents, Aier, Zibo Kangbei etc. Top 3 companies occupied about 81% market share.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hemoperfusion manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hemoperfusion Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Hemoperfusion Market Segment Percentages, by Type, 2022 (%)
    Activated Carbon Adsorption
    Resin Adsorption
Global Hemoperfusion Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Hemoperfusion Market Segment Percentages, by Application, 2022 (%)
    Hepatic Encephalopathy
    Certain Autoimmune Diseases
    Drug Overdose
    Specific Intoxications
    Others
Global Hemoperfusion Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Hemoperfusion Market Segment Percentages, By Region and Country, 2022 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hemoperfusion revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Hemoperfusion revenues share in global market, 2022 (%)
Key companies Hemoperfusion sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Hemoperfusion sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Jafron Biomedical
    Baxter (Gambro)
    Asahi-Kasei
    Biosun Medical
    Kaneka
    Toray Medical
    Cytosorbents
    Aier
    Zibo Kangbei
Outline of Major Chapters:
Chapter 1: Introduces the definition of Hemoperfusion, market overview.
Chapter 2: Global Hemoperfusion market size in revenue and volume.
Chapter 3: Detailed analysis of Hemoperfusion manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Hemoperfusion in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Hemoperfusion capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.